JESSE LEBARON: Open Payments
NPI 1851879217 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,120 in 129 payments from 24 companies in 2025. Trend: 2023 $3,459 · 2024 $4,126 · 2025 $4,120
Food & beverage: $3,859Education: $262
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $765 |
| ABBVIE INC. | 17 | $515 |
| Arcutis Biotherapeutics, Inc. | 10 | $486 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $390 |
| Galderma Laboratories, L.P. | 8 | $327 |
| UCB, Inc. | 3 | $182 |
| GENZYME CORPORATION | 6 | $172 |
| Botanix SB Inc | 4 | $155 |
| Organon LLC | 4 | $147 |
| Regeneron Healthcare Solutions, Inc. | 6 | $138 |
Products named: TREMFYA, Zoryve, NEMLUVIO, DUPIXENT, RINVOQ, ILUMYA, Bimzelx, SKYRIZI.
Industry payments across FL — which companies pay providers there.
